fbpx
Big Law

Novartis’ Alcon picks up PowerVision for $285M

Novartis subsidiary Alcon said today that it acquired intraocular lens developer PowerVision for $285 million.

PowerVision is developing fluid-based intraocular lens implants that use the eye’s natural accommodating response to transport fluid in the implanted lens, Fort Worth, Texas-based Alcon said.

Read the source article at MassDevice

Leave a Review or Comment

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close